Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Subhash C Arya

Showing results (131-140 of 259) with videos related to

Pageof 26
Sort By:
Clinical and Vaccine Immunology : CVI|January 30, 2013
Apropos "evaluation of serological diagnostic tests for typhoid Fever in papua new Guinea using a composite reference standard"Subhash C Arya, Nirmala Agarwal
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 2, 2013
Testing antimicrobial drugsSubhash C Arya, Nirmala Agarwal
Expert Opinion on Pharmacotherapy|April 30, 2013
Comment on: leishmaniasis: an update of current pharmacotherapySubhash C Arya, Nirmala Agarwal
The New England Journal of Medicine|November 27, 2009
A cluster-randomized effectiveness trial of Vi typhoid vaccine in IndiaSubhash C Arya, Nirmala Agarwal
Vaccine|January 2, 2010
Re: Hepatitis A and E: Update on prevention and epidemiologySubhash C Arya, Nirmala Agarwal
The Journal of Infection|November 18, 2005
Measles during pregnancy including neonatesSubhash C Arya, Nirmala Agarwal
Lancet (London, England)|August 21, 2003
Nosocomial infections in adult intensive-care unitsSubhash C Arya, Nirmala Agarwal
The Journal of Trauma|December 20, 2007
Re: Predictive value of sputum gram stain for the determination of appropriate antibiotic therapy in ventilator-associated pneumoniaSubhash C Arya, Nirmala Agarwal
European Journal of Internal Medicine|February 6, 2008
Regarding "Typhoid fever in travelers: time for re-assessment"Subhash C Arya, Nirmala Agarwal
BMJ (Clinical Research Ed.)|July 12, 2003
Neuraminidase inhibitors for influenza A and B: antivirals need to be protected from adverse conditions to retain effectivenessSubhash C Arya, Nirmala Agarwal
Pageof 26

Showing results (131-140 of 259) with videos related to

Sort By:
Pageof 26
Clinical and Vaccine Immunology : CVI|January 30, 2013
Apropos "evaluation of serological diagnostic tests for typhoid Fever in papua new Guinea using a composite reference standard"Subhash C Arya, Nirmala Agarwal
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 2, 2013
Testing antimicrobial drugsSubhash C Arya, Nirmala Agarwal
Expert Opinion on Pharmacotherapy|April 30, 2013
Comment on: leishmaniasis: an update of current pharmacotherapySubhash C Arya, Nirmala Agarwal
The New England Journal of Medicine|November 27, 2009
A cluster-randomized effectiveness trial of Vi typhoid vaccine in IndiaSubhash C Arya, Nirmala Agarwal
Vaccine|January 2, 2010
Re: Hepatitis A and E: Update on prevention and epidemiologySubhash C Arya, Nirmala Agarwal
The Journal of Infection|November 18, 2005
Measles during pregnancy including neonatesSubhash C Arya, Nirmala Agarwal
Lancet (London, England)|August 21, 2003
Nosocomial infections in adult intensive-care unitsSubhash C Arya, Nirmala Agarwal
The Journal of Trauma|December 20, 2007
Re: Predictive value of sputum gram stain for the determination of appropriate antibiotic therapy in ventilator-associated pneumoniaSubhash C Arya, Nirmala Agarwal
European Journal of Internal Medicine|February 6, 2008
Regarding "Typhoid fever in travelers: time for re-assessment"Subhash C Arya, Nirmala Agarwal
BMJ (Clinical Research Ed.)|July 12, 2003
Neuraminidase inhibitors for influenza A and B: antivirals need to be protected from adverse conditions to retain effectivenessSubhash C Arya, Nirmala Agarwal
Pageof 26